Response to long-term pharmacological management of metreleptin in a patient with monogenic obesity due to mutation in the LEP gene

Miguel Augusto O’Meara Novoa, Maria Camila Reyes Cajicá, Daniel Larrarte-Arenas, Jennifer Alexandra Palencia Ávila

Open source

DOI
10.1186/s40842-024-00207-3
Published
2025-07-07
Container
Cardiovascular Diabetology – Endocrinology Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40842-024-00207-3,
  title = {Response to long-term pharmacological management of metreleptin in a patient with monogenic obesity due to mutation in the LEP gene},
  author = {Miguel Augusto O’Meara Novoa and Maria Camila Reyes Cajicá and Daniel Larrarte-Arenas and Jennifer Alexandra Palencia Ávila},
  year = {2025},
  journal = {Cardiovascular Diabetology – Endocrinology Reports},
  doi = {10.1186/s40842-024-00207-3},
  url = {https://doi.org/10.1186/s40842-024-00207-3}
}

RIS

TY  - JOUR
TI  - Response to long-term pharmacological management of metreleptin in a patient with monogenic obesity due to mutation in the LEP gene
AU  - Miguel Augusto O’Meara Novoa
AU  - Maria Camila Reyes Cajicá
AU  - Daniel Larrarte-Arenas
AU  - Jennifer Alexandra Palencia Ávila
PY  - 2025
JO  - Cardiovascular Diabetology – Endocrinology Reports
DO  - 10.1186/s40842-024-00207-3
UR  - https://doi.org/10.1186/s40842-024-00207-3
ER  - 

APA

Novoa, M. A. O., Cajicá, M. C. R., Larrarte-Arenas, D., & Ávila, J. A. P. (2025). Response to long-term pharmacological management of metreleptin in a patient with monogenic obesity due to mutation in the LEP gene. Cardiovascular Diabetology – Endocrinology Reports. https://doi.org/10.1186/s40842-024-00207-3

Source records